Research Reflection: Moving research forward during COVID-19

Christine Maheu, Manon Lemonde, Samantha Mayo, Jacqueline Galica, Jill Bally

Abstract


The COVID-19 pandemic has led to major shifts in the healthcare environment, including the conduct of health research. Oncology practice has been significantly affected by abrupt measures to minimize COVID-19 exposure to cancer patients, family caregivers, and healthcare providers, such as social distancing, shifts to telehealth, redeployment and staffing changes, implementation of visitor restrictions, and round-the-clock use of personal protective equipment (Duncan et al., 2021). Efforts to minimize the risk of COVID-19 transmission also resulted in significant reductions in enrolling cancer patients in clinical trials in the early stages of the pandemic, especially for non-interventional studies (Tolaney et al., 2020; Waterhouse et al., 2020). 


Full Text:

PDF

References


Avis, N. E., Smith, K. W., Link, C. L., Hortobagyi, G. N., & Rivera, E. (2006). Factors associated with participation in breast cancer treatment clinical trials. Journal of Clinical Oncology, 24(12), 1860–1867. https://doi.org/10.1200/JCO.2005.03.8976

Borno, H. T., Zhang, L., Siegel, A., Chang, E., & Ryan, C. J. (2018). At what cost to clinical trial enrollment? A retrospective study of patient travel burden in cancer clinical trials. The Oncologist, 23(10), 1242–1249. https://doi.org/10.1634/theoncologist.2017-0628

Duncan, R., Szabo, B., Jackson, Q. L., Crain, M., Lett, C., Masters, C., Spinks, R., Uhrig, L. K., & Gullatte, M. M. (2021). Care and coping during COVID-19: Practice changes and innovations in the oncology setting. Clinical Journal of Oncology Nursing, 25(1), 48–55. https://doi.org/10.1188/21.CJON.48-55

Hamel, L. M., Penner, L. A., Albrecht, T. L., Heath, E., Gwede, C. K., & Eggly, S. (2016). Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control, 23(4), 327–337. https://doi.org/10.1177/107327481602300404

Sedrak, M. S., Freedman, R. A., Cohen, H. J., Muss, H. B., Jatoi, A., Klepin, H. D., Wildes, T. M., Le-Rademacher, J. G., Kimmick, G. G., Tew, W. P., George, K., Padam, S., Liu, J., Wong, A. R., Lynch, A., Djulbegovic, B., Mohile, S. G., Dale, W., & Cancer and Aging Research Group (CARG). (2021). Older adult participation in cancer clinical trials: A systematic review of barriers and interventions. CA: A Cancer Journal for Clinicians, 71(1), 78–92. https://doi.org/10.3322/caac.21638

Sellars, B. B., Sherrod, D. R., & Chappel-Aiken, L. (2018). Using word clouds to analyze qualitative data in clinical settings. Nursing Management, 49(10), 51–53. https://doi.org/10.1097/01.NUMA.0000546207.70574.c3

Tolaney, S. M., Lydon, C. A., Li, T., Dai, J., Standring, A., Legor, K. A., Caparrotta, C. M., Schenker, M. P., Glazer, D. I., Tayob, N., DuBois, S. G., Meyerhardt, J. A., Taplin, M.-E., & Johnson, B. E. (2020). The impact of COVID-19 on clinical trial execution at the Dana-Farber Cancer Institute. Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaa144

Waterhouse, D. M., Harvey, R. D., Hurley, P., Levit, L. A., Kim, E. S., Klepin, H. D., Mileham, K. F., Nowakowski, G., Schenkel, C., Davis, C., Bruinooge, S. S., & Schilsky, R. L. (2020). Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: Findings from an American Society of Clinical Oncology Survey. JCO Oncology Practice, 16(7), 417–421. https://doi.org/10.1200/OP.20.00275

Zanville, N., Cohen, B., Gray, T. F., Phillips, J., Linder, L., Starkweather, A., Yeager, K. A., & Cooley, M. E. (2021). The Oncology Nursing Society rapid review and research priorities for cancer care in the context of COVID-19. Oncology Nursing Forum, 48(2), 131–145. https://doi.org/10.1188/21.ONF.131-145


Refbacks

  • There are currently no refbacks.


Bookmark and Share